Call Us @ 0172 - 4680800 | info@indswift.com | NSE - BSE
Zika Vaccine Could Essentially Eliminate Prenatal Infection
 
A Zika vaccine could substantially prevent future outbreaks through a combination of direct protection and indirect transmission reduction, according to a modeling study published online April 3 in the Annals of Internal Medicine.
David P. Durham, Ph.D., from Yale University in New Haven, Conn., and colleagues developed a model to evaluate the impact of vaccine strategies on the incidence of prenatal Zika infections, including prioritization of females aged 9 to 49 years followed by males.

The researchers found that for a base-case vaccine efficacy of 75 percent and vaccination coverage of 90 percent, immunizing females aged 9 to 49 years would reduce the incidence of prenatal infections by at least 94 percent, depending on the country-specific Zika attack rate. Vaccination of women aged 15 to 29 years is more efficient than that of women aged 30 years or older in regions where an outbreak is not expected for at least 10 years.

"A Zika vaccine of moderate-to-high efficacy may virtually eliminate prenatal infections through a combination of direct protection and transmission reduction," the authors write. "Efficiency of age-specific targeting of Zika vaccination depends on the timing of future outbreaks."

(Drugs.com)
 
Other Related News:
2019 FDA Approved Drugs
FDA announces another carcinogenic impurity in ARB blood pressure drugs
Researchers identify common genetic signature among three rare skin diseases
Health ministry to amend Section 71 of D&C Rules to make Pharm D professionals eligible to supervise drug manufacturing
3rd International Diabetes Summit to be held in Pune from March 8-10, 2019
Health ministry to roll out common IT platform for management of sales and manufacturing licenses of drugs
Cosmetics licences may come with product composition details to enhance safety; new clause proposed in Cosmetics Rules 2018
T-cell specificity found to play a role in attacks on myelin versus β-synuclein in MS
Plazomicin noninferior to meropenem for complicated UTI
New molecules reverse memory loss linked to depression, aging